You Are Browsing ‘Health’ Category

Moody’s Investors Service said that Mylan NV (NASDAQ:MYL)’s offer to buy Perrigo Company Plc would be credit negative for the company. The acquisition may lead to higher leverage and integration risk. The investors service added that provided the sizeable equity component as proposed, the changed…

Mylan NV (NASDAQ:MYL) confirmed that its subsidiary firm, Mylan Pharmaceuticals Private Limited, introduced generic Sofosbuvir 400 mg tablets in India….

Merck & Co., Inc. (NYSE:MRK) reaffirmed its deep commitment to discovering and formulating novel medications in the global fight against severe infectious…

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has been facing a lot of troubles due to its cancer drug, Iclusig. The CEO of Ariad, Harvey J. Berger, has been…

AbbVie Inc (NYSE:ABBV) disclosed its decision to extend the deadline date of its exchange offer to acquire Pharmacyclics, Inc. (NASDAQ:PCYC). The company…

The Journal of the ‘American College of Cardiology’ reported data confirming the long-term efficacy and safety of the Boston Scientific Corporation…

Rite Aid Corporation (NYSE:RAD) has filed a lawsuit against Medicis Pharmaceutical Corp. stating that the company has been involved in malpractice. The…

A trial of Bristol-Myers Squibb Co (NYSE:BMY) Opdivo treatment has been concluded after proving it is effective against one of the most common forms of…

Merck & Co., Inc. (NYSE:MRK)‘s Keytruda was shown in a study to reduce tumors in almost half of advanced lung cancer patients. Now, the company…

Celgene Corporation (NASDAQ:CELG) has made a deal to purchase $45 million worth of Mesoblast’s shares. The top dollar buy off was a strategy for Celgene…

SPYR banner1